Governance

Setting out an ambitious strategy

and ensuring that it is implemented

The corporate governance of BIOASTER consists of a Board of Directors and a Scientific Advisory Board.

Philippe Archinard

Philippe Archinard – President

Board of directors

LYONBIOPÔLE

Florence Agostino-Etchetto

INSTITUT PASTEUR

Christophe d’Enfert

BIOMÉRIEUX

François Lacoste

BOEHRINGER- INGELHEIM

Christiane Wijsen

CNRS

Jean-Luc Moullet

CEA

Patrick Chaton

DANONE

Ongoing appointment

INSERM

Yazdan Yazdanpanah

INSTITUT MÉRIEUX

Jean-Luc Bélingard

SANOFI

Paul-Alan Dollinger

UNIVERSITÉ DE LYON

Frédéric Fleury

SME

Guy-Charles Fanneau de La Horie

SANOFI

Jacques Volckmann

Olivier Dugrip
Recteur de la région académique Auvergne-Rhône-Alpes, Chancelier des universités

LE MONDE VÉTÉRINAIRE

Mireille Bossy

LA METROPOLE DE LYON

Bruno Bernard

RÉGION AUVERGNE RHÔNE-ALPES

Laurent Wauquiez

MEDICEN

Ongoing appointment

DREETS

Angel Prieto

Management

Management team

Xavier Morge, CEO, Bioaster

Xavier Morge
CEO, PharmD, MBA

After a Doctorate in pharmacy, Xavier Morge started his career in 1998 as a Researcher-Engineer at CEA.
In parallel with his work, he co-founded SPI-Bio in 1991. After completing training in business management, he took over the general management of the company in 1996. He was confirmed in this role when the company joined Bertin Technologies in 2004. Within the group, Xavier was the architect of the development of the company, which combined organic growth and strategic acquisitions, leading to the creation of Bertin Pharma in 2010.

When the company had grown to have a workforce of around fifty, Xavier joined Oncodesign when it acquired Bertin. He then led the business development and marketing activities of Oncodesign. He was very active in the R&D ecosystem, participating in the creation of Afssi, of which he became President. He is also a Member of the Academy of Pharmacy.

Alexandre Moulin

Alexandre Moulin
Deputy CEO Administration and Public Affairs

Previously Director General of the Foundation for the University of Lyon.
Cyril Guyard

Cyril Guyard
Chief Scientific Officer & Director of Technologies, PhD

Previously

  • Deputy CSO & Director of Technologies, BIOASTER, Lyon
  • Principal Investigator and Molecular Microbiologist, Respiratory Infections, Public Health, Toronto, Ontario, Canada.
  • Assistant Professor in Medicine, Faculty of Department of Laboratory Medicine and Pathobiology, University of Toronto.
  • Scientist, Mount Sinai Hospital, Toronto, Ontario, Canada.